Hotchkis & Wiley Capital Management
CNMD icon

Hotchkis & Wiley Capital Management’s CONMED CNMD Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1M Buy
370,690
+53,240
+17% +$1.92M 0.04% 218
2026
Q1 		$11.2M Buy
+317,450
New +$12.9M 0.03% 207

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Hotchkis & Wiley Capital Management's CNMD Position: Q2 2026 in Review

Hotchkis & Wiley Capital Management increased its CONMED (CNMD) stake by 17% in Q2 2026, buying an estimated $1.92M and bringing the position to 370,690 shares worth $12.1M. The position accounts for 0.04% of the portfolio, ranked #218.

Hotchkis & Wiley Capital Management first reported a position in CNMD in Q1 2026 and has held it in 2 quarters since. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Hotchkis & Wiley Capital Management held 370,690 shares of CONMED worth $12.1M as of Q2 2026.
  • Hotchkis & Wiley Capital Management bought 53,240 CONMED shares in Q2 2026, an estimated $1.92M.
  • CONMED made up 0.04% of Hotchkis & Wiley Capital Management's portfolio in Q2 2026, its #218 holding.
  • Hotchkis & Wiley Capital Management first reported a position in CONMED in Q1 2026 and has held it in 2 quarters since.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.